Ion channels in death and differentiation of prostate cancer cells

被引:95
作者
Prevarskaya, N.
Skryma, R.
Bidaux, G.
Flourakis, M.
Shuba, Y.
机构
[1] Univ Lille 1, Lab Physiol Cellulaire, Equipe Labellisee Ligue Contre Canc, INSERM,U800, F-59650 Villeneuve Dascq, France
[2] NASU, Lab Mol Biophys, Bogomoletz Inst Physiol, UA-01024 Kiev 24, Ukraine
关键词
prostate cancer; ion channels; proliferation differentiation and apoptosis; volume regulation; calcium signaling; store-operated channels; TRP channels;
D O I
10.1038/sj.cdd.4402162
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Plasma membrane ion channels contribute to virtually all basic cellular processes, including such crucial ones for maintaining tissue homeostasis as proliferation, differentiation, and apoptosis. Enhanced proliferation, aberrant differentiation, and impaired ability to die are the prime reasons for abnormal tissue growth, which can eventually turn into uncontrolled expansion and invasion, characteristic of cancer. Prostate cancer (PCa) cells express a variety of plasma membrane ion channels. By providing the influx of essential signaling ions, perturbing intracellular ion concentrations, regulating cell volume, and maintaining membrane potential, PCa cells are critically involved in proliferation, differentiation, and apoptosis. PCa cells of varying metastatic ability can be distinguished by their ion channel characteristics. Increased malignancy and invasiveness of androgen-independent PCa cells is generally associated with the shift to a 'more excitable' phenotype of their plasma membrane. This shift is manifested by the appearance of voltage-gated Na+ and Ca2+ channels which contribute to their enhanced apoptotic resistance together with downregulated store-operated Ca2+ influx, altered expression of different K+ channels and members of the Transient Receptor Potential (TRP) channel family, and strengthened capability for maintaining volume constancy. The present review examines channel types expressed by PCa cells and their involvement in metastatic behaviors.
引用
收藏
页码:1295 / 1304
页数:10
相关论文
共 95 条
[31]   Clusterin expression is significantly enhanced in prostate cancer cells following androgen withdrawal therapy [J].
July, LV ;
Akbari, M ;
Zellweger, T ;
Jones, EC ;
Goldenberg, SL ;
Gleave, ME .
PROSTATE, 2002, 50 (03) :179-188
[32]   CaT1 knock-down strategies fail to affect CRAC channels in mucosal-type mast cells [J].
Kahr, H ;
Schindl, R ;
Fritsch, R ;
Heinze, B ;
Hofbauer, M ;
Hack, ME ;
Mörtelmaier, MA ;
Groschner, K ;
Peng, JB ;
Takanaga, H ;
Hediger, MA ;
Romanin, C .
JOURNAL OF PHYSIOLOGY-LONDON, 2004, 557 (01) :121-132
[33]   Identification of an HLA-A*0201-restricted T-cell epitope derived from the prostate cancer-associated protein trp-p8 [J].
Kiessling, A ;
Füssel, S ;
Schmitz, M ;
Stevanovic, S ;
Meye, A ;
Weigle, B ;
Klenk, U ;
Wirth, MP ;
Rieber, EP .
PROSTATE, 2003, 56 (04) :270-279
[34]   Voltage-dependent ion channel currents in putative neuroendocrine cells dissociated from the ventral prostate of rat [J].
Kim, JH ;
Shin, SY ;
Yun, SS ;
Kim, TJ ;
Oh, SJ ;
Kim, KM ;
Chung, YS ;
Hong, EK ;
Uhm, DY ;
Kim, SJ .
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2003, 446 (01) :88-99
[35]  
Kyprianou N, 2000, PROSTATE, P42
[36]   Ion channels in cell proliferation and apoptotic cell death [J].
Lang, F ;
Föller, M ;
Lang, KS ;
Lang, PA ;
Ritter, M ;
Gulbins, E ;
Vereninov, A ;
Huber, SM .
JOURNAL OF MEMBRANE BIOLOGY, 2005, 205 (03) :147-157
[37]  
Laniado ME, 2001, PROSTATE, V46, P262, DOI 10.1002/1097-0045(20010301)46:4<262::AID-PROS1032>3.0.CO
[38]  
2-F
[39]   Alterations in the regulatory volume decrease (RVD) and swelling-activated Cl- current associated with neuroendocrine differentiation of prostate cancer epithelial cells [J].
Lemonnier, L ;
Lazarenko, R ;
Shuba, Y ;
Thebault, S ;
Roudbaraki, M ;
Lepage, G ;
Prevarskaya, N ;
Skryma, R .
ENDOCRINE-RELATED CANCER, 2005, 12 (02) :335-349
[40]   Bcl-2-dependent modulation of swelling-activated Cl- current and ClC-3 expression in human prostate cancer epithelial cells [J].
Lemonnier, L ;
Shuba, Y ;
Crepin, A ;
Roudbaraki, M ;
Slomianny, C ;
Mauroy, B ;
Nilius, B ;
Prevarskaya, N ;
Skryma, R .
CANCER RESEARCH, 2004, 64 (14) :4841-4848